Emmessar Biotech And Nutrition (BOM:524768) Research & Development: ₹0.00 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:524768 Emmessar Biotech And Nutrition Ltd BOM:524768
55 GF Score
Price ₹25.34
GF Value ₹18.67
Valuation Significantly Overvalued
! 1 Warning Sign
View Full Analysis

What is Emmessar Biotech And Nutrition Research & Development?

Emmessar Biotech And Nutrition BOM:524768 +1.93% 55 Research & Development is ₹0.00 Mil as of Mar. 2026. GuruFocus rates BOM:524768 with a GF Score™ of 55/100 and a GF Value™ of ₹18.67 (Significantly Overvalued). The stock has 1 warning sign investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Emmessar Biotech And Nutrition's Research & Development for the three months ended in Mar. 2026 was ₹0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was ₹0.00 Mil.

Emmessar Biotech And Nutrition  (BOM:524768) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Emmessar Biotech And Nutrition Research & Development Related Terms

Emmessar Biotech And Nutrition Research & Development Historical Data

* Premium members only.

The historical data trend for Emmessar Biotech And Nutrition's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Emmessar Biotech And Nutrition Research & Development Chart

Emmessar Biotech And Nutrition Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Emmessar Biotech And Nutrition Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
BOM:524768
55GF Score
Emmessar Biotech And Nutrition Ltd BOM:524768
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Emmessar Biotech And Nutrition Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of ₹0.00 Mil mean?
Emmessar Biotech And Nutrition (BOM:524768) has a Research & Development of ₹0.00 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Emmessar Biotech And Nutrition and its competitors.
Is Emmessar Biotech And Nutrition's Research & Development too high?
Emmessar Biotech And Nutrition's current Research & Development is ₹0.00 Mil. Overall, Emmessar Biotech And Nutrition has a GF Score™ of 55/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Emmessar Biotech And Nutrition's Research & Development compare to ZTS?
Emmessar Biotech And Nutrition's Research & Development of ₹0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Drug Manufacturers company?
A good Research & Development depends on the Drug Manufacturers industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Emmessar Biotech And Nutrition and its competitors. Emmessar Biotech And Nutrition's current Research & Development is ₹0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Emmessar Biotech And Nutrition stock overvalued right now?
Based on GuruFocus' analysis, Emmessar Biotech And Nutrition (BOM:524768) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹18.67, compared to a current price of ₹25.34 — trading 35.7% above its estimated fair value. The current Research & Development is ₹0.00 Mil. Emmessar Biotech And Nutrition's overall GF Score™ is 55/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Emmessar Biotech And Nutrition (BOM:524768), the current Research & Development is ₹0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Emmessar Biotech And Nutrition (BOM:524768) Overvalued in 2026?

Based on GuruFocus' analysis, Emmessar Biotech And Nutrition stock appears to be overvalued. The current stock price of ₹25.34 is trading 35.7% above its estimated GF Value™ of ₹18.67. GuruFocus considers Emmessar Biotech And Nutrition to be Significantly Overvalued.

Key valuation signals for BOM:524768:

  • Research & Development: ₹0.00 Mil
  • GF Value™: ₹18.67 vs. price of ₹25.34 (35.7% above fair value)
  • GF Score™: 55/100 with 1 warning sign

No single metric tells the full story. See the BOM:524768 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Emmessar Biotech And Nutrition Business Description

Address 38, Cawasji Patel Street, 29, Kamer Building, 4th floor, Fort, Mumbai, MH, IND, 400001
Emmessar Biotech And Nutrition Ltd is a healthcare company. The company is engaged in the manufacturing and marketing of fine chemicals products, and healthcare and nutritional products. The company caters to patients with obstinate skin problems, muscle problems, bone problems, and other debilitating chronic physical ailments. The business segments of the company are Healthcare, Fine Chemicals, and Rent on Immovable property of which the majority of the revenue is derived from the Rent on Lease land segment.
55GF Score

Get the complete analysis for BOM:524768

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹25.34
Price
₹18.67
GF Value